Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SRPT
Recent news which mentions SRPT
< Previous
1
2
3
4
5
6
7
8
9
Next >
Sarepta Expects Prelim Gene Therapy Revenue To Be $131M In Q4, $200M For Fiscal Year
January 09, 2024
Tickers
NEWS
SRPT
Tags
Analyst Color
Top Stories
SRPT
From
Benzinga
Bumble (BMBL) Stock Pops as Elliott Builds a Stake in Rival Match
January 09, 2024
Tickers
BMBL
GRFS
MTCH
RENT
Tags
NASDAQ:BMBL,NASDAQ:MTCH,NASDAQ:GRFS,NASDAQ:SRPT,NASDAQ:RENT
BMBL
RENT
From
InvestorPlace
Why Is Sarepta Therapeutics (SRPT) Stock Up Today?
January 09, 2024
Tickers
JNPR
RENT
RKLB
SRPT
Tags
Market News
SRPT
JNPR
From
InvestorPlace
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
January 09, 2024
Tickers
ACCD
ACMR
AYI
CENX
Tags
OFIX
ILMN
NUKK
From
Benzinga
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
January 09, 2024
Tickers
DXCM
RHHBY
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
Tickers
ABBV
AMGN
BMY
CERE
Tags
BMY
Market News
SRPT
From
Benzinga
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
January 04, 2024
Tickers
ACLX
JNJ
LEGN
NEWS
Tags
LEGN
Analyst Color
Trading Ideas
From
Benzinga
3 Things About Sarepta Therapeutics Every Smart Investor Knows
December 28, 2023
Tickers
SRPT
Tags
SRPT
Market News
Recent Press Releases
From
Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
Tickers
CYTK
IOVA
ISRG
LLY
Tags
Benzinga
MRNA
LLY
From
Benzinga
Could Sarepta Therapeutics Be the Next Vertex Pharmaceuticals Stock?
December 22, 2023
Tickers
SRPT
VRTX
Tags
VRTX
SRPT
Recent Press Releases
From
Motley Fool
1 Revolutionary Stock That Could Make You Richer in 2024 and Beyond
December 17, 2023
Tickers
SRPT
Tags
SRPT
Market News
Recent Press Releases
From
Motley Fool
The Latest Analyst Ratings for Sarepta Therapeutics
December 12, 2023
Tickers
SRPT
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
Could Sarepta Therapeutics Stock Help You Become a Millionaire?
December 09, 2023
Tickers
SRPT
Tags
Market News
Recent Press Releases
SRPT
From
Motley Fool
My Take: 4 Strong Growth Stocks to Buy This Week
December 08, 2023
Tickers
AI
NIO
PYPL
SRPT
Tags
NIO
PYPL
AI
From
Motley Fool
Analyst Ratings for Sarepta Therapeutics
November 21, 2023
Tickers
SRPT
Tags
Benzinga
Analyst Ratings
BZI/AAR
From
Benzinga
3 Monster Stocks in the Making
November 18, 2023
Tickers
BEAM
CRSP
SRPT
Tags
SRPT
Recent Press Releases
Market News
From
Motley Fool
3 Stocks You’ll Regret Not Buying Soon: November 2023
November 16, 2023
Tickers
NXGL
RKLB
SRPT
Tags
Stocks to Buy
SRPT
Market News
From
InvestorPlace
Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy
November 15, 2023
Tickers
CTLT
SRPT
Tags
Benzinga
Movers
General
From
Benzinga
Jim Cramer Likes Founder Of AI Company, But Stock Is 'Losing A Fortune' And There's 'Too Much Hype There'
November 15, 2023
Tickers
AI
ALB
AMZN
BF-B
Tags
CNBC
News
Benzinga
From
Benzinga
Is Sarepta Therapeutics Stock a Bad-News Buy?
November 09, 2023
Tickers
SRPT
Tags
SRPT
Market News
Recent Press Releases
From
Motley Fool
1 Gene Therapy Stock to Buy and Hold for the Long Haul
November 08, 2023
Tickers
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
Is It Time to Buy the Nasdaq's 4 Worst-Performing October Stocks?
November 08, 2023
Tickers
ALGN
LSCC
SEDG
SRPT
Tags
LSCC
ALGN
SEDG
From
Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
Tickers
ABT
ACRS
BMY
CI
Tags
VTYX
ACRS
REPL
From
Benzinga
Analyst Ratings for Sarepta Therapeutics
November 02, 2023
Tickers
SRPT
Tags
SRPT
Market News
Analyst Ratings
From
Benzinga
Sarepta Therapeutics (SRPT) Q3 2023 Earnings Call Transcript
November 02, 2023
Tickers
SRPT
Tags
SRPT
Recent Press Releases
Market News
From
Motley Fool
Earnings Scheduled For November 1, 2023
November 01, 2023
Tickers
QCOM
QDEL
QNST
QRVO
Tags
SRPT
SHC
BZI/UE
From
Benzinga
What's Going On With Biotech Contract Service Firm Catalent Stock Today?
October 31, 2023
Tickers
CTLT
SRPT
Tags
Movers
Benzinga
News
From
Benzinga
Uphill Battle Ahead For Gene Therapy Player Sarepta, Analysts Lower Price Targets Following Duchenne Trial Miss
October 31, 2023
Tickers
SRPT
Tags
Market News
Price Target
SRPT
From
Benzinga
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Tickers
AIRE
ANET
ANVS
ATXI
Tags
PSMT
RGEN
TTI
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 31, 2023
Tickers
ATXI
CDIO
EIGR
EVAX
Tags
Benzinga
Movers
CDIO
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.